CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CanadaBis Capital Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CanadaBis Capital Inc
255C Clearview Drive
Phone: (587) 356-5625p:587 356-5625 RED DEER COUNTY, AB  T4E 3B6  Canada Ticker: CANBCANB
Business Summary
CanadaBis Capital Inc. is a vertically integrated Canadian cannabis company. The Company’s principal business is the production and sale of recreational cannabis and cannabis extracts. The Company operates through three segments: Cultivation and wholesale, Retail and Extract. The Cultivation and wholesale segment is engaged in cultivating and distributing cannabis and cannabis products to and through, provincial liquor and cannabis boards, which are subsequently sold to end consumers. Its Retail segment is involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the Company. Its Extract segment provides cannabinoid extraction services for the Company and also to other licensed producers. The Company’s subsidiaries include Stigma Pharmaceuticals Inc., 1998643 Alberta Ltd., Full Spectrum Labs Ltd., 2103157 Alberta Ltd., and Goldstream Cannabis Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20247/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
5999 Miscellaneous retail stores, not elsewhere classified
0139 Field crops, except cash grains, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Director TravisMcintyre 42 1/1/2022 4/1/2019
Chief Financial Officer GarfieldRichards 9/1/2023 9/1/2023
Corporate Secretary, Director BarbaraOneill 56 11/1/2016 11/1/2016
Independent Director NicoleBacsalmasi 41 5/1/2023 5/1/2023
Independent Director AlexMichaud 74 4/1/2019 4/1/2019

Business Names
Business Name
1926360 Alberta Ltd.
CANB
CANB.P
Full Spectrum Labs Ltd.
Stigma Pharmaceuticals

General Information
Outstanding Shares: 138,256,380 (As of 1/31/2024)
Stock Exchange: CVE
Fax Number: (587) 356-5625


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 29, 2024